Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets (Parentheticals)

v3.25.4
Consolidated Balance Sheets (Parentheticals) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Accounts receivable, net of allowance $ 76 $ 23
Preferred stock, par value (in Dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in Shares) 10,000,000 10,000,000
Common stock, par value (in Dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in Shares) 300,000,000 300,000,000
Common stock, shares issued (in Shares) 77,306,972 76,565,072
Common stock, shares outstanding (in Shares) 77,306,972 76,565,072
Series A Preferred Stock    
Preferred stock, shares authorized (in Shares) 1,684,375 1,684,375
Preferred stock, shares issued (in Shares)
Preferred stock, shares outstanding (in Shares)
Series B Preferred Stock    
Preferred stock, shares authorized (in Shares) 1,580,790 1,580,790
Preferred stock, shares issued (in Shares) 926,942 926,942
Preferred stock, shares outstanding (in Shares) 926,942 926,942
Preferred stock, liquidation preference $ 18,075  
Non-Voting Common Stock    
Common stock, par value (in Dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in Shares) 3,553,000 3,553,000
Common stock, shares issued (in Shares) 896 896
Common stock, shares outstanding (in Shares) 896 896